Sibutramine, an anorexic drug affecting both 5-HT and NA tone by inhibiting 5-HTT and NAT has shown good therapeutic efficacy with regard to weight reduction in the treatment of severe obesity [25]. The gene discussed is SLC6A4; the disease is obesity disorder.